Denise Dignam
Denise Dignam's purchase track record
Denise Dignam has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/11/2026 | CC | $51K | pending | pending | — |
| 8/8/2025 | CC | $49K | +3.2% | +52.3% | +8.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Chemours Q2 Earnings Call and UBS Price Target Cut. Chemours released its Q2 2026 earnings call transcript, providing details on its financial performance. UBS kept a neutral stance but lowered its price target to $16, reflecting a more cautious view of the company's outlook. The new target sits below the current average analyst target of $18.22 and near the support level of $15.07, indicating a potential short‑term pressure on the stock.
Transaction History
| KLIC | ▲ Buy | Grant | 493 | $0 | 10/5/2026 | View on chart |
| CC | ▲ Buy | Open Market | 3,378 | $51K | 8/11/2026 | View on chart |
| CC | ▼ Sell | Tax Withholding | 477 | $8K | 8/1/2026 | View on chart |
| KLIC | ▲ Buy | Grant | 407 | $0 | 7/6/2026 | View on chart |
| KLIC | ▲ Buy | Grant | 675 | $0 | 4/6/2026 | View on chart |
| CC | ▲ Buy | Grant | 169,538 | $0 | 3/2/2026 | View on chart |
| CC | ▼ Sell | Tax Withholding | 22,220 | $405K | 3/1/2026 | View on chart |
| CC | ▲ Buy | Grant | 2,261 | $0 | 2/24/2026 | View on chart |
| CC | ▼ Sell | Tax Withholding | 742 | $14K | 2/24/2026 | View on chart |
| KLIC | ▲ Buy | Grant | 876 | $0 | 1/5/2026 | View on chart |
| KLIC | ▲ Buy | Grant | 1,081 | $0 | 10/6/2025 | View on chart |
| CC | ▲ Buy | Open Market | 4,068 | $49K | 8/8/2025 | View on chart |
| CC | ▼ Sell | Tax Withholding | 466 | $5K | 8/1/2025 | View on chart |
| KLIC | ▲ Buy | Grant | 1,260 | $0 | 7/1/2025 | View on chart |
| KLIC | ▲ Buy | Grant | 1,343 | $0 | 4/1/2025 | View on chart |
| CC | ▲ Buy | Grant | 106,421 | $0 | 3/3/2025 | View on chart |
| CC | ▼ Sell | Tax Withholding | 4,818 | $72K | 3/1/2025 | View on chart |
| KLIC | ▲ Buy | Grant | 956 | $0 | 1/2/2025 | View on chart |
| KLIC | ▲ Buy | Grant | 1,025 | $0 | 10/1/2024 | View on chart |
| CC | ▼ Sell | Tax Withholding | 303 | $7K | 8/1/2024 | View on chart |
| KLIC | ▲ Buy | Grant | 933 | $0 | 7/1/2024 | View on chart |
| CC | ▲ Buy | Grant | 34,431 | $0 | 5/8/2024 | View on chart |
| KLIC | ▲ Buy | Grant | 891 | $0 | 4/1/2024 | View on chart |
| CC | ▼ Sell | Tax Withholding | 3,058 | $88K | 3/27/2024 | View on chart |
| CC | ▲ Buy | Grant | 9,496 | $0 | 3/27/2024 | View on chart |
| CC | ▼ Sell | Tax Withholding | 1,299 | $27K | 3/1/2024 | View on chart |
| KLIC | ▲ Buy | Grant | 853 | $0 | 1/2/2024 | View on chart |
| KLIC | ▲ Buy | Grant | 931 | $0 | 10/2/2023 | View on chart |
| KLIC | ▲ Buy | Grant | 380 | $0 | 8/22/2023 | View on chart |
| CC | ▲ Buy | Grant | 2,712 | $0 | 8/1/2023 | View on chart |
| CC | ▼ Sell | Tax Withholding | 569 | $21K | 3/2/2023 | View on chart |
| CC | ▼ Sell | Tax Withholding | 522 | $18K | 3/1/2023 | View on chart |
| CC | ▲ Buy | Grant | 5,919 | $0 | 3/1/2023 | View on chart |
| CC | ▲ Buy | Grant | 14,351 | $0 | 3/1/2023 | View on chart |
| CC | ▼ Sell | Tax Withholding | 2,248 | $68K | 11/7/2022 | View on chart |
| CC | ▼ Sell | Tax Withholding | 584 | $16K | 3/2/2022 | View on chart |
| CC | ▼ Sell | Tax Withholding | 453 | $12K | 3/1/2022 | View on chart |
| CC | ▲ Buy | Grant | 2,117 | $0 | 3/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Kulicke & Soffa Shares Rise Amid Positive Earnings Call Coverage
Kulicke & Soffa shares have seen recent gains, highlighted by a positive Q3 2026 earnings call and favorable commentary from financial media. The company is also featured in a list of semiconductor and power management stocks showing strong price movement. While the stock trades well above its 52-week low, the current price sits below the average analyst target price.
Kulicke & Soffa Shares Rise Amid Positive Earnings Call Coverage. Kulicke & Soffa shares have seen recent gains, highlighted by a positive Q3 2026 earnings call and favorable commentary from financial media. The company is also featured in a list of semiconductor and power management stocks showing strong price movement. While the stock trades well above its 52-week low, the current price sits below the average analyst target price.